Searching For Real Value In Market Debris At G1 Therapeutics Inc. (NASDAQ: GTHX)

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for G1 Therapeutics Inc. (GTHX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.08, or -0.62%, to $12.85. Volume reached 1,106 shares, with price reaching a high of $12.77 and a low of $11.7. Yahoo Finance discussed the stock recently as it posted G1 Therapeutics to Participate Virtually in the H.C. Wainwright 24th Annual Global Investment Conference.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

Stocks Info

As a NASDAQ listed company, GTHX falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $12.77 and fluctuated between $13.20 as its day high and $11.90 as its day low. The current market capitalization of G1 Therapeutics Inc. is $554.47M. A total of 1.39 million shares were traded on the day, compared to an average of 1.10M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, GTHX has seen 6 BUY and 3 SELL insider trades, representing the acquisition of 130,000 and the disposition of 81,296 shares. Over the last 12 months, there were 18 BUYs and 9 SELLs from insiders. Insiders purchased 309,333 shares during that period but sold 122,646.

In the most recent transaction, Velleca Mark A. sold 20,000 shares of GTHX for 13.50 per share on Sep 20. After the transaction, the Director now owns 116,000 company shares. In a previous transaction on Sep 13, Malik Rajesh sold 18,000 shares at 15.71 per share. GTHX shares that Chief Medical Officer owns now total 73,207.

Among the insiders who sold shares, Velleca Mark A. disposed of 80,000 shares on Aug 16 at a per-share price of $12.64. This resulted in the Director holding 116,000 shares of GTHX after the transaction. In another insider transaction, Malik Rajesh sold 648 shares at $5.17 per share on Jul 05. Company shares held by the Chief Medical Officer now total 73,207.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for GTHX in the last 3 months, the mean price target is $35.43 with high estimates of $67.00 and low estimates of $14.00. In terms of 52-week highs and lows, GTHX has a high of $17.49 and a low of $3.84.

As of this writing, GTHX has an earnings estimate of $-0.64 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $-0.44 per share and a lower estimate of $-0.94. The company reported an EPS of $-0.92 in the last quarter, which was 11.54% higher than expectations of $-1.04.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GTHX is Overweight with a score of 4.14. A total of 6 analysts rated the stock as Buy while 1 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

292
294

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.